Similar Items: The Indiana University Brain Health Program to deliver amyloid‐targeted therapy to Alzheimer's disease patients
- White matter hyperintensities in Alzheimer's disease in the era of anti‐amyloid therapies
- Identification of patients receiving amyloid‐targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADS
- Exploring the spatial covariance of cerebral vascular density and amyloid burden in Alzheimer's disease
- Reframing Alzheimer's disease as a complex adaptive system: More than an amyloid beta–tau connection
- Anti‐amyloid therapy eligibility in a longitudinal brain‐donor cohort with post mortem confirmation
- Investigating the amyloid–tau–neurodegeneration framework in Alzheimer's disease using semi‐supervised multimodal imaging data fusion